Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (2): 231-236.doi: 10.19982/j.issn.1000-6621.20240424

• Review Articles • Previous Articles     Next Articles

The research progress on the relationship between serum albumin and its derivative biomarkers and chronic obstructive pulmonary disease

Fu Ying1, Xiong Yangyang1, Fang Si2, Li Chuanxiang2, Guo Hongrong2()   

  1. 1Department of Medicine, Wuhan University of Science and Technology, Wuhan 430081, China
    2Department of Respiratory and Critical Care Medicine, Wuhan Third Hospital and Tongren Hospital Affiliated to Wuhan University, Wuhan 430060, China
  • Received:2024-09-24 Online:2025-02-10 Published:2025-02-08
  • Contact: Guo Hongrong, Email: hyg6808@sina.com
  • Supported by:
    Wuhan Preventive Medicine Research Special Fund(WY22A08)

Abstract:

Chronic obstructive pulmonary disease (COPD) is a widespread chronic inflammatory lung disease characterized by airflow limitation and partial irreversibility. The pathogenesis of COPD is complex, involving inflammatory responses, oxidative stress, and proteases anti-proteases imbalance. Serum albumin (ALB) and its derivative biomarkers, as bioindicators of nutritional status and inflammatory response, play an important role in the pathogenesis, disease assessment, and prognosis of COPD. At present, no comprehensive review on the relationship between COPD and serum albumin and its derivative biomarkers has been published. This review synthesizes the latest research findings to deepen our understanding of the role of these biomarkers in COPD and to highlight their potential research value.

Key words: Pulmonary disease, chronic obstructive, Serum albumin, Biological markers, Review literature as topic

CLC Number: